As of Nov 25
| +0.80 / +20.15%|
The 2 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 22.50, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +371.70% increase from the last price of 4.77.
The current consensus among 2 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.